Provident Trust Co. cut its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.7% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 921,202 shares of the healthcare conglomerate’s stock after selling 6,742 shares during the quarter. UnitedHealth Group accounts for 8.2% of Provident Trust Co.’s holdings, making the stock its 3rd largest position. Provident Trust Co. owned 0.09% of UnitedHealth Group worth $170,809,000 as of its most recent SEC filing.
A number of other large investors have also recently made changes to their positions in UNH. Waldron LP increased its stake in UnitedHealth Group by 153.1% in the first quarter. Waldron LP now owns 5,765 shares of the healthcare conglomerate’s stock valued at $944,000 after acquiring an additional 3,487 shares during the last quarter. Empire Life Investments Inc. increased its stake in UnitedHealth Group by 3.9% in the first quarter. Empire Life Investments Inc. now owns 25,171 shares of the healthcare conglomerate’s stock valued at $3,530,000 after acquiring an additional 949 shares during the last quarter. Elkhorn Investments LLC bought a new position in UnitedHealth Group in the first quarter valued at approximately $1,122,000. Public Employees Retirement Association of Colorado increased its stake in UnitedHealth Group by 13.9% in the first quarter. Public Employees Retirement Association of Colorado now owns 783,190 shares of the healthcare conglomerate’s stock valued at $128,451,000 after acquiring an additional 95,874 shares during the last quarter. Finally, MCF Advisors LLC increased its stake in UnitedHealth Group by 55.2% in the first quarter. MCF Advisors LLC now owns 1,214 shares of the healthcare conglomerate’s stock valued at $199,000 after acquiring an additional 432 shares during the last quarter. 86.17% of the stock is currently owned by institutional investors and hedge funds.
In other news, insider Thomas E. Roos sold 975 shares of the company’s stock in a transaction dated Thursday, October 19th. The shares were sold at an average price of $205.47, for a total transaction of $200,333.25. Following the transaction, the insider now owns 24,630 shares in the company, valued at $5,060,726.10. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Gail R. Wilensky sold 5,600 shares of the company’s stock in a transaction dated Tuesday, September 5th. The shares were sold at an average price of $199.49, for a total transaction of $1,117,144.00. Following the transaction, the director now owns 60,834 shares in the company, valued at approximately $12,135,774.66. The disclosure for this sale can be found here. Insiders have sold 72,149 shares of company stock worth $14,212,342 in the last quarter. Company insiders own 0.89% of the company’s stock.
UnitedHealth Group Incorporated (NYSE UNH) traded down $0.49 during mid-day trading on Friday, reaching $211.07. 1,384,700 shares of the company traded hands, compared to its average volume of 3,134,052. The firm has a market capitalization of $205,015.92, a price-to-earnings ratio of 22.04, a price-to-earnings-growth ratio of 1.57 and a beta of 0.64. The company has a current ratio of 0.70, a quick ratio of 0.72 and a debt-to-equity ratio of 0.52. UnitedHealth Group Incorporated has a 1-year low of $146.01 and a 1-year high of $213.93.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share for the quarter, beating the consensus estimate of $2.57 by $0.09. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The firm had revenue of $50.32 billion for the quarter, compared to analyst estimates of $50.38 billion. During the same quarter in the prior year, the business earned $2.17 earnings per share. The business’s quarterly revenue was up 8.7% compared to the same quarter last year. equities analysts anticipate that UnitedHealth Group Incorporated will post 9.99 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 12th. Stockholders of record on Friday, December 1st will be issued a dividend of $0.75 per share. The ex-dividend date of this dividend is Thursday, November 30th. This represents a $3.00 annualized dividend and a dividend yield of 1.42%. UnitedHealth Group’s dividend payout ratio is currently 33.26%.
TRADEMARK VIOLATION NOTICE: “UnitedHealth Group Incorporated (UNH) is Provident Trust Co.’s 3rd Largest Position” was originally reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this report on another publication, it was stolen and reposted in violation of United States and international copyright and trademark laws. The correct version of this report can be viewed at https://www.dispatchtribunal.com/2017/11/11/provident-trust-co-decreases-position-in-unitedhealth-group-inc-unh.html.
A number of brokerages recently issued reports on UNH. Zacks Investment Research cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, November 2nd. Credit Suisse Group started coverage on shares of UnitedHealth Group in a research note on Thursday, November 2nd. They issued an “outperform” rating and a $233.00 price objective on the stock. Mizuho reaffirmed a “buy” rating on shares of UnitedHealth Group in a research note on Tuesday, October 24th. Oppenheimer Holdings, Inc. boosted their target price on shares of UnitedHealth Group from $215.00 to $205.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 18th. Finally, Sanford C. Bernstein reaffirmed an “outperform” rating and set a $219.00 target price (up previously from $210.00) on shares of UnitedHealth Group in a research note on Thursday, October 19th. Three equities research analysts have rated the stock with a hold rating and twenty-four have issued a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus price target of $216.65.
UnitedHealth Group Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.